Lesson 14 min 20 XP
Health Economics in Development
How disease, malnutrition, and weak health systems trap countries in poverty, and which interventions deliver the greatest impact.
Ask about this lesson
For the complete documentation index, see llms.txt.Skip to main content
How disease, malnutrition, and weak health systems trap countries in poverty, and which interventions deliver the greatest impact.
Health and economic development are locked in a vicious or virtuous cycle. Poor health reduces productivity: a worker with malaria loses an average of 5-20 working days per episode. Childhood malnutrition -- which affects roughly 150 million children under five -- permanently impairs cognitive development, reducing lifetime earnings by an estimated 10-17%. HIV/AIDS killed a generation of prime-age workers in southern Africa, devastating economies and leaving millions of orphans.
At the macro level, economists Jeffrey Sachs and others have estimated that malaria alone reduces GDP growth by 1.3 percentage points per year in heavily affected countries. The Commission on Macroeconomics and Health calculated that investing $66 per person per year in health interventions in low-income countries could generate economic returns of $360 billion annually by 2020. The returns on health investment are enormous -- the challenge is delivering care in settings with few doctors, weak infrastructure, and limited funding.
Some health interventions are among the most cost-effective development investments known. Insecticide-treated bed nets cost roughly $2-3 each and reduce malaria transmission by 50%. Oral rehydration therapy for diarrheal disease costs pennies and saves millions of lives. Childhood vaccination programs are estimated to return $16 for every $1 invested through reduced healthcare costs and increased productivity.
The challenge is health system strengthening -- building the infrastructure, workforce, and supply chains needed to deliver these interventions at scale. Sub-Saharan Africa has roughly 0.2 physicians per 1,000 people, compared to 3.5 in the EU. Training more health workers, building supply chains for essential medicines, and creating referral systems between community health workers and hospitals are essential but unglamorous investments that receive less attention than disease-specific programs.